What Are Mononuclear Cells? Their Types and Functions

Mononuclear cells are white blood cells that share one defining physical trait: a single, round or kidney-shaped nucleus. This distinguishes them from other white blood cells like neutrophils and eosinophils, which have multi-lobed nuclei and are collectively called polymorphonuclear cells. The mononuclear family includes lymphocytes (T cells, B cells, and natural killer cells), monocytes, and dendritic cells. Together, they orchestrate nearly every aspect of the immune response, from recognizing a new pathogen to remembering it years later. The term comes up constantly in lab reports, immunology research, and clinical discussions about cancer or autoimmune disease, yet it is really just a structural label for a diverse group of cells that do very different jobs.

The Major Types of Mononuclear Cells

Although they look similar under a standard microscope, mononuclear cells fall into functionally distinct categories. The broadest split is between lymphocytes and monocytes. Lymphocytes are the smaller cells and include T cells, B cells, and natural killer (NK) cells. Monocytes are larger, with a characteristic kidney-bean-shaped nucleus, and they serve as precursors to macrophages and some dendritic cells once they leave the bloodstream. Dendritic cells, while less abundant, are sometimes grouped under the mononuclear umbrella because of their single nucleus and their origin from monocyte-like precursors.

In a typical blood sample, lymphocytes make up the majority of circulating mononuclear cells, with T cells alone accounting for roughly two-thirds of them. Monocytes usually represent a smaller fraction, and dendritic cells are rarer still. When researchers or clinicians refer to “peripheral blood mononuclear cells” (PBMCs), they mean this entire pool of single-nucleated immune cells isolated from blood, excluding red blood cells, platelets, and the multi-lobed white blood cells.

T Cells and Their Specialized Subsets

T cells are arguably the most versatile members of the mononuclear family. They mature in the thymus and are responsible for cell-mediated immunity, meaning they directly target infected or abnormal cells rather than relying solely on antibodies. The two best-known branches are helper T cells (CD4+) and cytotoxic T cells (CD8+). Helper T cells do not kill targets themselves; instead, they coordinate the immune response by releasing signaling molecules called cytokines that activate other immune cells.

Helper T cells are further divided into subsets with distinct jobs. The traditional classification recognized Th1 and Th2 cells, but more recently discovered subsets like Th17, follicular helper T cells (Tfh), and regulatory T cells (Tregs) have expanded the picture considerably. Each subset drives a different flavor of immune activity: Th1 cells push cell-mediated responses against intracellular pathogens, Th2 cells promote antibody production and are central to allergic reactions, and Th17 cells are involved in defense against fungi and bacteria at mucosal surfaces. Tregs, meanwhile, act as brakes on the system, dampening excessive immune responses to prevent autoimmune damage.¹

Cytotoxic T cells (CD8+) are the immune system’s assassins. They recognize cells displaying abnormal proteins on their surface, whether from a viral infection or a cancerous mutation, and kill them directly. This is why CD8+ T cells are a major focus in cancer immunotherapy research.

B Cells and Antibody Production

B cells are the architects of what immunologists call humoral immunity. Their headline role is producing antibodies, Y-shaped proteins that latch onto specific targets (antigens) and either neutralize them directly or flag them for destruction by other immune cells. But B cells do more than make antibodies. They also present antigens to T cells and secrete cytokines that can either ramp up or dial down immune activity.²

After encountering a pathogen, some B cells become long-lived memory cells that persist for years or even decades. These memory B cells are the reason vaccines work: when the same pathogen shows up again, the immune system already has cells primed and ready to churn out antibodies within hours instead of days. This dual capacity for antibody production and immune regulation makes B cells central players in both protection and, when things go wrong, autoimmune disease.

Natural Killer Cells

Natural killer (NK) cells occupy an unusual position. They are lymphocytes by classification, but they behave more like innate immune cells because they do not need prior exposure to a threat before attacking it. NK cells were originally discovered about four decades ago based on their ability to kill tumor cells without any prior sensitization or priming. Since then, researchers have confirmed that NK cells also recognize and destroy virus-infected cells.³

One of their key tricks is detecting cells that have lost the surface markers healthy cells normally display. The idea, sometimes called the “missing self” hypothesis, is straightforward: viruses and cancer often cause cells to downregulate these markers to evade T cells, but that same disappearing act makes them visible to NK cells. NK cells also carry out antibody-dependent cell-mediated cytotoxicity (ADCC), meaning they can destroy targets that have been coated by antibodies. This makes them valuable partners to the antibody-producing B cells.

Monocytes, Macrophages, and Dendritic Cells

Monocytes circulate in the blood for a day or two before migrating into tissues, where they mature into macrophages or dendritic cells depending on local signals. Macrophages are the cleanup crew: they engulf dead cells, debris, and pathogens through a process called phagocytosis. But they also serve as sentinels, detecting danger signals and releasing cytokines that recruit other immune cells to the scene.

Tissue-resident macrophages are a remarkably diverse group. The liver has Kupffer cells, the brain has microglia, the lungs have alveolar macrophages, and the bones have osteoclasts. These resident populations perform tissue-specific housekeeping functions ranging from iron processing to clearing cellular debris, alongside their broader role in immune surveillance and responding to infection.⁴ Even within a single organ, macrophages in different sub-tissue niches can run distinct programs, reflecting how precisely the local environment shapes cell behavior.⁵

Dendritic cells are the immune system’s messengers. They patrol tissues, pick up antigens from pathogens or damaged cells, and then migrate to lymph nodes where they present those antigens to T cells. This antigen presentation step is critical: without it, T cells would have no way of knowing what to attack. Dendritic cells process proteins into small fragments, load them onto surface molecules, and essentially show T cells what the threat looks like, initiating targeted immune responses or, in some cases, tolerance to harmless substances.⁶

How PBMCs Are Isolated in the Lab

If you have ever read about immunology experiments or clinical trials involving immune cells, you have almost certainly come across the abbreviation PBMC. Isolating these cells from a blood draw is one of the most routine procedures in immunology, and it relies on a surprisingly simple principle: mononuclear cells are lighter than red blood cells and granulocytes. By layering blood over a density gradient medium and spinning it in a centrifuge, researchers can separate PBMCs into a distinct band that is easy to collect.⁷

The classic medium for this is Ficoll-Hypaque, which has been used for decades. An alternative called Percoll offers one advantage: Ficoll can slightly alter the density of monocytes, making them harder to separate cleanly from lymphocytes afterward, whereas Percoll avoids this issue and gives a better split between the two populations.⁸ The choice of method matters when researchers need highly pure subsets for downstream applications like flow cytometry, gene expression profiling, or cell therapy manufacturing.

Mononuclear Cells in Cancer

Tumors do not exist in isolation. They are infiltrated by immune cells, and the makeup of that infiltrate tells a lot about how the cancer is likely to behave. Tumor-infiltrating lymphocytes (TILs), especially CD8+ T cells, are generally considered the frontline defenders against tumor cells. Tumor-associated macrophages (TAMs) are more complicated: depending on the signals they receive in the tumor microenvironment, they can either fight tumor growth or actively promote it.⁹

In clinical practice, the balance between lymphocytes and monocytes in the blood has emerged as a surprisingly informative prognostic marker across several cancer types. In Hodgkin lymphoma, for example, an absolute monocyte count above a certain threshold is associated with worse progression-free survival, and this held up even after adjusting for other known risk factors.¹⁰ Similar findings apply to diffuse large B-cell lymphoma, where a low lymphocyte count paired with a high monocyte count predicted shorter survival.¹¹ In acute myeloid leukemia, a high monocyte count after initial treatment independently predicted poorer outcomes.¹²

Research in nasopharyngeal cancer has gone further by linking the circulating lymphocyte-to-monocyte ratio with what is actually happening inside the tumor. Higher ratios correlated with better three-year progression-free survival, and so did higher densities of CD8+ T cells within the tumor tissue. Conversely, a high density of CD163+ macrophages (a marker associated with pro-tumor polarization) was linked to dramatically worse outcomes.¹³ The broader takeaway is that looking at any single mononuclear cell type in isolation often misses the picture. A comprehensive scoring system that evaluates both lymphocytes and macrophages together in the tumor microenvironment outperforms single-cell assessments when predicting patient outcomes.¹⁴

When Mononuclear Cells Drive Disease

The same cells that protect you can turn against you. In autoimmune diseases like rheumatoid arthritis, lupus, and multiple sclerosis, mononuclear cells attack the body’s own tissues. B cells contribute to autoimmunity through multiple pathways: they produce autoantibodies (antibodies that target the body’s own proteins), present self-antigens to T cells, secrete inflammatory cytokines, and can even form ectopic germinal centers in inflamed tissues where they continue to generate pathogenic immune responses.¹⁵ Recent work confirms that autoreactive B cells contribute not only through autoantibody production but also through antigen presentation and cytokine secretion, perpetuating a cycle that sustains disease.¹⁶

Chronic inflammation is another context where mononuclear cells play a central but damaging role. In conditions like rheumatoid arthritis, lymphocytes and monocytes migrate through blood vessel walls into the inflamed tissue. Once there, they release cytokines like interferon-gamma, interleukin-1, and tumor necrosis factor, which in turn make the blood vessel lining even stickier and attract still more mononuclear cells, creating a self-amplifying inflammatory loop.¹⁷

Certain viruses exploit this biology as well. Monocytes and macrophages can serve as viral reservoirs, harboring viruses for long periods within tissues. Some viruses use these cells mainly as hiding places for long-term persistence, while others actively replicate inside them. Either way, the strategy lets viruses evade immune clearance by residing inside the very cells meant to eliminate them.¹⁸

Mononuclear Cells in Cell Therapy

One of the most high-profile applications of mononuclear cell biology is CAR-T cell therapy, a treatment in which a patient’s own T cells are collected, genetically engineered to recognize a specific cancer marker, and then infused back into the body. The process starts with leukapheresis, a procedure that selectively draws mononuclear cells from the blood.¹⁹ T cells are then isolated from this collection, modified in the lab, expanded to large numbers, and returned to the patient. CAR-T therapy has shown dramatic results in certain blood cancers, and researchers are working to extend the approach to solid tumors as well.

Beyond CAR-T, PBMC isolation underpins a wide range of immunological research. Single-cell RNA sequencing of PBMCs can now identify dozens of distinct cell clusters within a single blood draw, revealing subtleties in immune composition that were invisible with older technologies. Researchers have used this approach to map immune cell populations in conditions ranging from coronary artery disease to aging, identifying as many as 33 distinct cell clusters among tens of thousands of individual cells from a single study.

How Aging Reshapes Mononuclear Cell Populations

The immune system does not stay the same over a lifetime. Aging brings measurable changes to mononuclear cell composition and function, a process broadly known as immunosenescence. A study comparing PBMCs from younger and older adults found hundreds of genes that differed between the two groups at baseline, with pathways related to DNA damage, telomere stress, and oxidative stress standing out among the age-related changes.²⁰ Interestingly, a single bout of high-intensity exercise triggered more pronounced gene expression changes in the PBMCs of older adults than in younger ones, suggesting the aging immune system responds differently to acute physiological stress.

Not all aging trajectories are equal, though. Single-cell analysis of blood from centenarians and supercentenarians has revealed that these exceptionally long-lived people show a distinctive immune profile. Their blood is enriched in CD8+ effector memory T cells and terminally differentiated B cells, while their CD14+ monocytes display heightened antigen-presenting ability, potentially helping to sustain active T and B cell responses despite advanced age.²¹ This kind of adaptive immune remodeling may be part of what allows some individuals to maintain robust immune function well past the point where most people’s immunity has declined.

Mononuclear Cells Across Species

Mononuclear cells are not unique to humans. The core immune cell types, including macrophages, T cells, and B cells, are present across vertebrates from fish to mammals, reflecting deep evolutionary conservation. Single-cell sequencing across seven species, from zebrafish to humans, has confirmed that macrophages share conserved functions in pathogen phagocytosis, cell migration, and pro-inflammatory signaling across all of these groups, even though the specific genes performing those tasks differ between species.²²

Comparative work across amniotes (a group including reptiles, birds, and mammals) has identified roughly 30 distinct mononuclear phagocyte and lymphocyte cell types in chickens and 31 in humans, with a smaller count in turtles. But beneath this structural similarity lies substantial molecular divergence: fewer than one in ten expressed genes showed fully conserved expression patterns across species, which suggests that while the cellular architecture of the mononuclear immune system is ancient, the molecular details have been continually reworked by evolution.²³ Even in trout, macrophages share a morphology recognizable to anyone who has studied mammalian macrophages, complete with an irregular nucleus and pseudopods, and they test positive for the same nonspecific esterase enzymes used as markers in human pathology, though they lack some mammalian surface markers like CD68.²⁴

The practical implication is that animal models of immune function, from zebrafish to mice, share enough of the mononuclear cell toolkit to be useful for studying human disease. But the molecular differences are real enough that findings do not always translate directly, something researchers need to keep in mind when moving between species.